Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review
RES Corporation
On this page
Company details
- Legal name
- The Royal Eswatini Sugar Corporation Limited
- Listing
- RSC on the Eswatini Stock Exchange, active · ISIN SZ0005797920 (observed 2026-10-06)
- Sector
- Not classified (our classification from the stated principal activity)
- Financial year ends
- 31 March
Overview
Year ended 31 March 2025 · published summary of audited statements, final status not established · source
Read with these figures
- Published summary of audited statements not confirmed as final. The published copy is not confirmed as the final version. The FY to 31 Mar 2025 figures come from it.
Full wording and sources
Published summary of audited statements for 2025: final status not established
Published by the company through the ESE. No auditor's report on the condensed results is printed: under 'Review by Independent Auditors' the company states that SNG Grant Thornton Chartered Accountants (Eswatini) reviewed the press release and issued an unmodified report on the audited consolidated results, which is available for inspection; no auditor's signature or report date is shown. Board block 'For and on behalf of the Board' with the typed names Dr A T Dlamini and N M Jackson, Simunye, 24 June 2025, and no signatures (PDF p1, page image).
Source: The Royal Eswatini Sugar Corporation Limited and its Subsidiaries Condensed Results for the year ended 31 March 2025 (dated 2025-06-24)
2025, 2024: figures from a published summary
These columns come from a summary of the audited statements, not the full audited financial statements. 'This summarised consolidated financial information has been derived from the audited financial statements and is consistent in all material respects.' (Review by Independent Auditors, p1); 'The condensed consolidated financial information, which has been audited, has been drawn up in compliance with ...' (Statement of Compliance, p1) No auditor's report on the summary is printed. The summary states (p1, 'Review by Independent Auditors'): 'The Group auditors, SNG Grant Thornton Chartered Accountants (Eswatini), have reviewed this press release. The Group auditors have audited the consolidated financial results for the year ended 31 March 2025 and have issued an unmodified report. This summarised consolidated financial information has been derived from the audited financial statements and is consistent in all material respects. The report of the independent auditors is available for inspection at the registered office of the Company.' Column headings print 'Audited'. Condensed consolidated statement of comprehensive income (with OCI; profit printed as 'attributable to owners of the Company', no NCI line), statement of financial position (no total liabilities or non-current liabilities subtotal; equity and non-current liabilities share one unlabelled subtotal), cash flows (condensed), changes in equity, segment analysis (external revenue and segment results), production statistics and ratios; no notes. Statement of changes in equity, segments, statistics and ratios not transcribed.
Source: The Royal Eswatini Sugar Corporation Limited and its Subsidiaries Condensed Results for the year ended 31 March 2025 (dated 2025-06-24)
-
Revenue
SZL 4.96 billion
4,963,924 SZL thousands · p1
+4.5% vs 2024
-
Operating profit / (loss)
SZL 520 million
520,292 SZL thousands · p1
−29.6% vs 2024
-
Profit / (loss) for the year
SZL 423 million
423,115 SZL thousands · p1
−33.7% vs 2024
-
Total assets
SZL 5.79 billion
5,789,971 SZL thousands · p1
+9.7% vs 2024
-
Total equity
SZL 3.26 billion
3,259,256 SZL thousands · p1
+5.1% vs 2024
-
Cash from operations
SZL 593 million
593,487 SZL thousands · p1
−9.7% vs 2024
Large amounts are rounded for reading (SZL million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.
Financial statements
Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in SZL thousands unless the row says otherwise; brackets are negative.
† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table
Column sources
- FY to 31 Mar 2025 — published summary of audited statements (summary), final status not established; reported for the year · source
- FY to 31 Mar 2024 — published summary of audited statements (summary), final status not established; comparative in the FY to 31 Mar 2025 filing · source
- 2025, 2024: figures from a published summary. These columns come from a summary of the audited statements, not the full audited financial statements. 'This summarised consolidated financial information has been derived from the audited financial statements and is consistent in all material respects.' (Review by Independent Auditors, p1); 'The condensed consolidated financial information, which has been audited, has been drawn up in compliance with ...' (Statement of Compliance, p1) No auditor's report on the summary is printed. The summary states (p1, 'Review by Independent Auditors'): 'The Group auditors, SNG Grant Thornton Chartered Accountants (Eswatini), have reviewed this press release. The Group auditors have audited the consolidated financial results for the year ended 31 March 2025 and have issued an unmodified report. This summarised consolidated financial information has been derived from the audited financial statements and is consistent in all material respects. The report of the independent auditors is available for inspection at the registered office of the Company.' Column headings print 'Audited'. Condensed consolidated statement of comprehensive income (with OCI; profit printed as 'attributable to owners of the Company', no NCI line), statement of financial position (no total liabilities or non-current liabilities subtotal; equity and non-current liabilities share one unlabelled subtotal), cash flows (condensed), changes in equity, segment analysis (external revenue and segment results), production statistics and ratios; no notes. Statement of changes in equity, segments, statistics and ratios not transcribed.
Income statement
| Line (as printed) | FY to 31 Mar 2025Published summary of audited statements (summary)reported for the year | FY to 31 Mar 2024Published summary of audited statements (summary)comparative in FY to 31 Mar 2025 filingsource limitations |
|---|---|---|
| Revenue | 4,963,924 | 4,749,409 |
| Cost of sales | (3,897,812) | (3,778,978) |
| Change in fair value of biological assets1 | (16,792) | 280,265 |
| Gross profit | 1,049,320 | 1,250,696 |
| Other income | 121,967 | 90,074 |
| Distribution expenses | (12,991) | (10,547) |
| Administration expenses | (636,660) | (590,366) |
| Impairment loss on trade receivables | (1,344) | (1,080) |
| Operating profit | 520,292 | 738,777 |
| Finance income | 56,261 | 51,711 |
| Finance costs | (63,155) | (62,455) |
| Net finance costs2 | (6,894) | (10,744) |
| (net of income tax) | 39,832 | 48,050 |
| Profit before taxation | 553,230 | 776,083 |
| Income tax expense | (130,115) | (137,613) |
| P r o f i t a t t r i b u t a b l e t o o w n e r s o f th e C o m p a n y | 423,115 | 638,470 |
| Remeasurements of defined benefit liability3 | (11,692) | 4,595 |
| Related tax4 | 2,923 | (1,264) |
| Other comprehensive income (net of tax) | (8,769) | 3,331 |
| of the Company | 414,346 | 641,801 |
Notes and alternative reported figures (4)
- “Change in fair value of biological assets” is an issuer-specific line, not mapped to a shared definition: Included in gross profit.
- “Net finance costs” is an issuer-specific line, not mapped to a shared definition: Finance income less finance costs.
- “Remeasurements of defined benefit liability” is an issuer-specific line, not mapped to a shared definition: OCI, items never reclassified, before tax.
- “Related tax” is an issuer-specific line, not mapped to a shared definition: Tax on OCI remeasurements.
Balance sheet
| Line (as printed) | FY to 31 Mar 2025Published summary of audited statements (summary)reported for the year | FY to 31 Mar 2024Published summary of audited statements (summary)comparative in FY to 31 Mar 2025 filingsource limitations |
|---|---|---|
| Property, plant and equipment | 2,870,295 | 2,718,123 |
| Goodwill1 | 286,481 | 286,481 |
| Intangible assets | 48,146 | 39,696 |
| Equity accounted investees | 256,007 | 238,536 |
| Deferred tax assets | 1 | 1 |
| Non-current assets (unlabelled subtotal) | 3,460,930 | 3,282,837 |
| Inventories | 257,239 | 217,761 |
| Biological assets - growing cane2 | 1,010,519 | 1,027,738 |
| Biological assets - livestock3 | 17,505 | 17,078 |
| Trade and other receivables | 622,889 | 459,572 |
| Taxation prepaid | 287 | 67 |
| Derivative assets | –4 | 2,426 |
| Cash and cash equivalents | 420,602 | 272,014 |
| Current assets (unlabelled subtotal) | 2,329,041 | 1,996,656 |
| Total assets | 5,789,971 | 5,279,493 |
| O r d i n a r y s h a r e h o l d e r s ' fu n d s | 3,259,256 | 3,100,228 |
| D e f e r r e d t a x l i a b i l i t i e s | 719,101 | 654,615 |
| Lo a n s a n d b o r r o w i n g s | 649,420 | 536,106 |
| Employee benefits5 | 110,249 | 102,440 |
| Equity and non-current liabilities (unlabelled subtotal)6 | 4,738,026 | 4,393,389 |
| Trade and other payables | 543,650 | 437,330 |
| Short term employee benefits7 | 108,940 | 138,478 |
| Bank overdraft | 47,205 | 11,281 |
| Current portion of loans and borrowings | 201,622 | 148,635 |
| C u r r e n t ta x l i a b il i ties | 19,692 | 9,139 |
| D iv i d e n d s p a y a b l e | 130,836 | 141,241 |
| Current liabilities (unlabelled subtotal) | 1,051,945 | 886,104 |
| T o tal eq u ity a n d liabilities | 5,789,971 | 5,279,493 |
- Printed “-”, read as nil: subtotal_arithmetic: bs.current_assets.
Notes and alternative reported figures (6)
- “Goodwill” is an issuer-specific line, not mapped to a shared definition: Non-current asset.
- “Biological assets - growing cane” is an issuer-specific line, not mapped to a shared definition: Current asset.
- “Biological assets - livestock” is an issuer-specific line, not mapped to a shared definition: Current asset.
- “Employee benefits” is an issuer-specific line, not mapped to a shared definition: Printed under equity and non-current liabilities.
- “Equity and non-current liabilities (unlabelled subtotal)” is an issuer-specific line, not mapped to a shared definition: Unlabelled subtotal closing the section headed 'Equity and non-current liabilities'.
- “Short term employee benefits” is an issuer-specific line, not mapped to a shared definition: Current liability.
Cash flow
| Line (as printed) | FY to 31 Mar 2025Published summary of audited statements (summary)reported for the year | FY to 31 Mar 2024Published summary of audited statements (summary)comparative in FY to 31 Mar 2025 filingsource limitations |
|---|---|---|
| C a s h g e n e r a te d fr o m o p e r a tions1 | 832,603 | 758,457 |
| C h a n g e s in w o r k in g c a p it a l2 | (126,013) | 20,132 |
| Finance costs3 | (60,729) | (59,715) |
| Taxation paid | (52,374) | (61,410) |
| Net cash generated from operating activities | 593,487 | 657,464 |
| A c q u i s i t i o n o f p r o p e r t y , p la n t a nd equipment | (421,085) | (354,617) |
| A c q u i s i t i o n o f in t a n g i b l e a ss e t s | (29,907) | (13,282) |
| Acquisition of equity in associate company4 | 0 | (13,158) |
| Other investing activities5 | 80,098 | 79,561 |
| Net cash utilised in investing activities | (370,894) | (301,496) |
| Net increase in loans and borrowings6 | 156,729 | 81,685 |
| Dividends paid | (265,723) | (129,685) |
| N e t c a s h u ti l i s e d i n f i n a n c i n g a c t i v i t i e s | (108,994) | (48,000) |
| N e t in c r e a s e i n c a s h a n d c a s h e q u i v a l e n t s | 113,599 | 307,968 |
| Ca s h a n d ca s h e q u i v a l e n t s a t b e g i n n i n g o f y ear | 260,733 | (50,961) |
| Effect of exchange rate fluctuations on cash held | (936) | 3,726 |
| Cash and cash equivalents at end of the period | 373,396 | 260,733 |
Notes and alternative reported figures (6)
- “C a s h g e n e r a te d fr o m o p e r a tions”: mapping to a shared definition is uncertain. Printed 'Cash generated from operations', before changes in working capital (printed next). Text layer stores this row character-spaced; label recorded as the text layer holds it (printed 'Cash generated from operations' on the render); digits joined by the re-read; compared on the render.
- “C h a n g e s in w o r k in g c a p it a l” is an issuer-specific line, not mapped to a shared definition: Operating: printed after cash generated from operations.
- “Finance costs”: mapping to a shared definition is uncertain. Printed 'Finance costs' in the operating section; not stated as interest paid. The 2024 cell is merged with commentary text in the re-read; read on the render.
- “Acquisition of equity in associate company” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Other investing activities” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Net increase in loans and borrowings” is an issuer-specific line, not mapped to a shared definition: Financing: net movement in loans and borrowings.
Segments
Segment data not yet collected for this company in the pilot.
Dividends
Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.
| Year ended | Event | Wording as printed | Amount | Unit | Source |
|---|---|---|---|---|---|
| 31 Mar 2025 | Dividend declared per share, as printed in a statement | Dividends per share (cents)Interim 129.2 plus final 135.8 cents declared for the year (commentary). |
2.650 | SZL per share | Summary statements, p1 |
| 31 Mar 2025 | Dividends paid (cash flow statement) | Dividends paid |
(265,723) | SZL thousands | Summary statements, p1 |
| 31 Mar 2024 | Dividend declared per share, as printed in a statement | Dividends per share (cents)Interim 129.2 plus final 135.8 cents declared for the year (commentary). |
2.812 | SZL per share | Summary statements, p1 |
| 31 Mar 2024 | Dividends paid (cash flow statement) | Dividends paid |
(129,685) | SZL thousands | Summary statements, p1 |
Sources
Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.
-
The Royal Eswatini Sugar Corporation Limited and its Subsidiaries Condensed Results for the year ended 31 March 2025
Year ended 31 March 2025 · Published summary of audited statements (summary) · final status not established
Audit: SNG Grant Thornton Chartered Accountants (Eswatini) (named); no auditor's opinion on the full statements in this document · no signature page in this document
Final status: Published by the company through the ESE. No auditor's report on the condensed results is printed: under 'Review by Independent Auditors' the company states that SNG Grant Thornton Chartered Accountants (Eswatini) reviewed the press release and issued an unmodified report on the audited consolidated results, which is available for inspection; no auditor's signature or report date is shown. Board block 'For and on behalf of the Board' with the typed names Dr A T Dlamini and N M Jackson, Simunye, 24 June 2025, and no signatures (PDF p1, page image).
- Document date
- 24 Jun 2025
- Published
- 26 Jun 2025
- Auditor's report
- date not recorded
- Board approval
- 24 Jun 2025
- Retrieved by us
- 8 Oct 2026 (not a publication date)
- Used for
- statement columns FY to 31 Mar 2025, FY to 31 Mar 2024
- Basis
- consolidated statements · SZL thousands (printed “E'000”)
- Printed 'The Royal Eswatini Sugar Corporation Limited and its subsidiaries' (registration number 197710032001568; ESE share code RSSC; ISIN SZ0005797920; header on the render, p1); the directory name is 'Royal Eswatini Sugar Corporation (RSSC)', ticker RSC, same ISIN. Same legal entity.
- Closing cash in the cash-flow statement at 31 March 2025 is 373 396; cash and cash equivalents (420 602) less bank overdraft (47 205) in the statement of financial position give 373 397 (difference 1, rounding). Kept as printed; checked on the render.
- The registration number, ESE share code and ISIN in the header are part of an image without text layer; read on the render. Many rows are stored character-spaced in the text layer (see the transcriber's note in each mapping).
- Basic earnings per share (439.2; 2024: 662.7) and dividends per share (265.0; 2024: 281.2) printed in cents; stored in emalangeni with the printed figure and unit kept. Shares in issue printed in thousands (96 346).
- No auditor's report on the summary is printed. The summary states (p1, 'Review by Independent Auditors'): 'The Group auditors, SNG Grant Thornton Chartered Accountants (Eswatini), have reviewed this press release. The Group auditors have audited the consolidated financial results for the year ended 31 March 2025 and have issued an unmodified report. This summarised consolidated financial information has been derived from the audited financial statements and is consistent in all material respects. The report of the independent auditors is available for inspection at the registered office of the Company.' Column headings print 'Audited'.
- Condensed consolidated statement of comprehensive income (with OCI; profit printed as 'attributable to owners of the Company', no NCI line), statement of financial position (no total liabilities or non-current liabilities subtotal; equity and non-current liabilities share one unlabelled subtotal), cash flows (condensed), changes in equity, segment analysis (external revenue and segment results), production statistics and ratios; no notes. Statement of changes in equity, segments, statistics and ratios not transcribed.
Technical details
- File
- 1 pages, with a text layer
- SHA-256
aa564a1f7c3807badc2e3ce0d01abb3ac344cbe2197ba51b1d981907093ea78d- Entity as printed
- THE ROYAL ESWATINI SUGAR CORPORATION LIMITED AND ITS SUBSIDIARIES (Registration number: 197710032001568; Share Code: RSSC; ISIN SZ0005797920)
- Exchange copy
- retrieved 2026-10-08T18:04:05Z
Data notes
No figure-level notes beyond those in the tables.
Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.
Download
Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.